ANCILLARY SUPPLY CHAIN EXPERTISEAncillare Insights
1 in 10 Sponsors cite a lack of technology integration as their biggest clinical trial pain point.
Learn more about what Ancillare is doing to bring sophisticated Clinical Trial Ancillary Supply Chain (CTASC™) technology dashboards to its Sponsor and CRO partners.
As major world events continue to unfold, every organization is contending with supply chain disruptions. Challenges with Clinical Trial Ancillary Supply Chain (CTASC™) are not going away. Ancillare remains at the forefront of supply chain innovation, and stays committed to helping Sponsors overcome setbacks and achieve their clinical trial milestones.
Today’s clinical research environment requires cooperation and insight across countless organizations, teams, and specialists. More and more, Sponsors are turning to trusted third parties with high levels of expertise to make their trials run effectively.
A lack of correct ancillary supplies can be the difference between a clinical trial starting on time or having to delay at significant cost to the sponsor. The Covid-19 pandemic exacerbated what would already be a difficult task of sourcing and purchasing trial equipment. Ancillare CEO Joanne Santomauro explains how the situation developed and how her company stayed ahead of the curve and minimised the impact of shortages in the supply chain.
January is Cervical Health Awareness Month. Dr. John Fitzgerald, Medical Director and Subject Matter Expert at Ancillare, shares insights from decades in the women’s health field to raise awareness of cervical cancer and other conditions, discuss the importance of preventive services, and highlight the potential of Decentralized Trials to advance necessary research.
PharmaVOICE Supply Chain SHOWCASE: The Cost of Overlooking Ancillary Supplies in Protocol Development
What will it take to overcome grand-scale supply chain challenges, avoid massive business ramifications, and produce the best possible outcomes for patients worldwide?
As the effects of the pandemic reverberate through global supply chains, Sponsors still face many hurdles in sourcing and managing ancillary supplies for clinical trials. Interruptions and delays that once felt like temporary inconveniences are now long-term realities across the entire industry, and there is no choice except to adapt.
Dr. Joanne Santomauro, Chief Executive Officer and Founder of Ancillare, LP, created the Clinical Trial Ancillary Supply Chain (CTASC™) Management industry in 2006. Joanne’s 35 years of supply chain management expertise led the company to launch its market-leading model. Her leadership has resulted in Ancillare’s explosive growth throughout the world.
Our work to make clinical trials run more smoothly helps our partners create hope for patients every day, all over the world.
Minimizing interruptions in your Clinical Trial Ancillary Supply Chain lowers risk of delay in your trial timeline — potentially saving millions in overall trial costs.
Ancillare’s CEO, Dr. Joanne Santomauro, discusses how the organization overcame supply chain challenges in the height of the COVID-19 pandemic to source ancillary supplies for clinical trials.
Talk with Our Ancillary Supply Chain Experts
Tell us a little about your project or ancillary supply challenges, and we will set up a consultation with our team.